Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 10 Jun 2024 13:55:34 +0200Tue, 09 Jan 2024 16:35:00 +0100Vazkepa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5398_en_1.pdfVazkepa : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5398_en_1.pdfTue, 09 Jan 2024 16:35:00 +0100Human medicineHuman medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Date of authorisation: 26/03/2021, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vazkepaHuman medicines European public assessment report (EPAR): Vazkepa, icosapent ethyl, Date of authorisation: 26/03/2021, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/vazkepaTue, 09 Jan 2024 12:17:00 +0100Human medicine